Catherine M. Bollard Center for Cell and Gene Therapy Baylor College of Medicine Biography Publications Institution JoVE Articles Catherine M. Bollard has not added a biography. If you are Catherine M. Bollard and would like to personalize this page please email our Author Liaison for assistance. Publications Immunotherapy. Apr, 2012 | Pubmed ID: 22512624 Experimental Hematology. Apr, 2012 | Pubmed ID: 22507641 Expert Review of Hematology. Apr, 2012 | Pubmed ID: 22475282 Good T Cells for Bad B Cells Blood. Mar, 2012 | Pubmed ID: 22442331 Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Feb, 2012 | Pubmed ID: 22306904 Ex Vivo Fucosylation Improves Human Cord Blood Engraftment in NOD-SCID IL-2Rγnull (NSG) Mice Experimental Hematology. Feb, 2012 | Pubmed ID: 22306295 Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2012 | Pubmed ID: 22226092 Production of Good Manufacturing Practice-grade Cytotoxic T Lymphocytes Specific for Epstein-Barr Virus, Cytomegalovirus and Adenovirus to Prevent or Treat Viral Infections Post-allogeneic Hematopoietic Stem Cell Transplant Cytotherapy. Jan, 2012 | Pubmed ID: 22172091 Aggressive Peripheral CD70-positive T-cell Lymphoma Associated with Severe Chronic Active EBV Infection Pediatric Blood & Cancer. Oct, 2011 | Pubmed ID: 21994111 Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2011 | Pubmed ID: 21915103 Improving T-cell Therapy for Relapsed EBV-negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2011 | Pubmed ID: 21908573 Experimental Hematology. Oct, 2011 | Pubmed ID: 21767511 CD28 Costimulation Improves Expansion and Persistence of Chimeric Antigen Receptor-modified T Cells in Lymphoma Patients The Journal of Clinical Investigation. May, 2011 | Pubmed ID: 21540550 Cytotherapy. Sep, 2011 | Pubmed ID: 21539497 Characterization and Treatment of Chronic Active Epstein-Barr Virus Disease: a 28-year Experience in the United States Blood. Jun, 2011 | Pubmed ID: 21454450 Pediatric Hematology and Oncology. Apr, 2011 | Pubmed ID: 21381869 Good Manufacturing Practice-grade Cytotoxic T Lymphocytes Specific for Latent Membrane Proteins (LMP)-1 and LMP2 for Patients with Epstein-Barr Virus-associated Lymphoma Cytotherapy. May, 2011 | Pubmed ID: 21361747 Blood. Feb, 2011 | Pubmed ID: 21310929 Novel Cord Blood Transplant Therapies Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2011 | Pubmed ID: 20951821 Lovastatin Inhibits T-cell Proliferation While Preserving the Cytolytic Function of EBV, CMV, and MART-1-specific CTLs Journal of Immunotherapy (Hagerstown, Md. : 1997). Nov-Dec, 2010 | Pubmed ID: 20948439 Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients with Locoregional Nasopharyngeal Carcinoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Nov-Dec, 2010 | Pubmed ID: 20948438 Cytotherapy. Nov, 2010 | Pubmed ID: 20942604 Improving Clinical Outcomes Using Adoptively Transferred Immune Cells from Umbilical Cord Blood Cytotherapy. Oct, 2010 | Pubmed ID: 20818913 Allogeneic Virus-specific T Cells with HLA Alloreactivity Do Not Produce GVHD in Human Subjects Blood. Nov, 2010 | Pubmed ID: 20709906 Blood. Nov, 2010 | Pubmed ID: 20671118 Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That is Reversed with IL-2 Exvivo Expansion Journal of Immunotherapy (Hagerstown, Md. : 1997). Sep, 2010 | Pubmed ID: 20664358 Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: a 10-year Experience Cytotherapy. Oct, 2010 | Pubmed ID: 20429793 Antigen-specific Cytotoxic T Lymphocytes Can Target Chemoresistant Side-population Tumor Cells in Hodgkin Lymphoma Leukemia & Lymphoma. May, 2010 | Pubmed ID: 20367572 Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Sep, 2010 | Pubmed ID: 20348004 Derivation of Human T Lymphocytes from Cord Blood and Peripheral Blood with Antiviral and Antileukemic Specificity from a Single Culture As Protection Against Infection and Relapse After Stem Cell Transplantation Blood. Apr, 2010 | Pubmed ID: 20110422 Computer-assisted Quantitative Evaluation of Therapeutic Responses for Lymphoma Using Serial PET/CT Imaging Academic Radiology. Apr, 2010 | Pubmed ID: 20060747 Long-term Outcome of EBV-specific T-cell Infusions to Prevent or Treat EBV-related Lymphoproliferative Disease in Transplant Recipients Blood. Feb, 2010 | Pubmed ID: 19880495 Mediterranean Journal of Hematology and Infectious Diseases. 2009 | Pubmed ID: 21416001 Repetitive Noninvasive Monitoring of HSV1-tk-expressing T Cells Intravenously Infused into Nonhuman Primates Using Positron Emission Tomography and Computed Tomography with 18F-FEAU Molecular Imaging. Jul-Aug, 2009 | Pubmed ID: 19728977 Cytotoxic T Lymphocyte Therapy with Donor T Cells Prevents and Treats Adenovirus and Epstein-Barr Virus Infections After Haploidentical and Matched Unrelated Stem Cell Transplantation Blood. Nov, 2009 | Pubmed ID: 19700662 Noninvasive Bioluminescent Imaging Demonstrates Long-term Multilineage Engraftment of Ex Vivo-expanded CD34-selected Umbilical Cord Blood Cells Stem Cells (Dayton, Ohio). Aug, 2009 | Pubmed ID: 19544439 Functionally Active Virus-specific T Cells That Target CMV, Adenovirus, and EBV Can Be Expanded from Naive T-cell Populations in Cord Blood and Will Target a Range of Viral Epitopes Blood. Aug, 2009 | Pubmed ID: 19443656 Journal of Immunotherapy (Hagerstown, Md. : 1997). Apr, 2009 | Pubmed ID: 19242369 Enhancing the in Vivo Expansion of Adoptively Transferred EBV-specific CTL with Lymphodepleting CD45 Monoclonal Antibodies in NPC Patients Blood. Mar, 2009 | Pubmed ID: 18971421 Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Nov, 2008 | Pubmed ID: 18940685 Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Nov, 2008 | Pubmed ID: 18940679 Leukemia & Lymphoma. 2008 | Pubmed ID: 18821430 Best Practice & Research. Clinical Haematology. Sep, 2008 | Pubmed ID: 18790446 Deficient T(H)-1 Responses from TNF-alpha-matured and Alpha-CD40-matured Dendritic Cells Journal of Immunotherapy (Hagerstown, Md. : 1997). Feb-Mar, 2008 | Pubmed ID: 18481385 Antitumor Activity of EBV-specific T Lymphocytes Transduced with a Dominant Negative TGF-beta Receptor Journal of Immunotherapy (Hagerstown, Md. : 1997). Jun, 2008 | Pubmed ID: 18463534 Identification of Hexon-specific CD4 and CD8 T-cell Epitopes for Vaccine and Immunotherapy Journal of Virology. Jan, 2008 | Pubmed ID: 17942545 Complete Responses of Relapsed Lymphoma Following Genetic Modification of Tumor-antigen Presenting Cells and T-lymphocyte Transfer Blood. Oct, 2007 | Pubmed ID: 17609424 Autologous Designer Antigen-presenting Cells by Gene Modification of T Lymphocyte Blasts with IL-7 and IL-12 Journal of Immunotherapy (Hagerstown, Md. : 1997). Jul-Aug, 2007 | Pubmed ID: 17589291 Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Dec, 2006 | Pubmed ID: 17162209 Monoculture-derived T Lymphocytes Specific for Multiple Viruses Expand and Produce Clinically Relevant Effects in Immunocompromised Individuals Nature Medicine. Oct, 2006 | Pubmed ID: 16998485 Adoptive Immunotherapy for Hodgkin's Lymphoma International Journal of Hematology. Jun, 2006 | Pubmed ID: 16787867 In Vivo Expansion of LMP 1- and 2-specific T-cells in a Patient Who Received Donor-derived EBV-specific T-cells After Allogeneic Stem Cell Transplantation Leukemia & Lymphoma. May, 2006 | Pubmed ID: 16753867 Assessing the Safety of Cytotoxic T Lymphocytes Transduced with a Dominant Negative Transforming Growth Factor-beta Receptor Journal of Immunotherapy (Hagerstown, Md. : 1997). May-Jun, 2006 | Pubmed ID: 16699368 Immunology and Cell Biology. Jun, 2006 | Pubmed ID: 16681825 Administration of Latent Membrane Protein 2-specific Cytotoxic T Lymphocytes to Patients with Relapsed Epstein-Barr Virus-positive Lymphoma Clinical Lymphoma & Myeloma. Jan, 2006 | Pubmed ID: 16507214 Adenoviral Infections in Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Mar, 2006 | Pubmed ID: 16503493 Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-positive Nasopharyngeal Carcinoma and Lymphoma Journal of Immunology (Baltimore, Md. : 1950). Sep, 2005 | Pubmed ID: 16148164 Treatment of Nasopharyngeal Carcinoma with Epstein-Barr Virus--specific T Lymphocytes Blood. Mar, 2005 | Pubmed ID: 15542583 Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease The Journal of Experimental Medicine. Dec, 2004 | Pubmed ID: 15611290 The Generation and Characterization of LMP2-specific CTLs for Use As Adoptive Transfer from Patients with Relapsed EBV-positive Hodgkin Disease Journal of Immunotherapy (Hagerstown, Md. : 1997). Jul-Aug, 2004 | Pubmed ID: 15235393 Adoptive Immunotherapy for Posttransplantation Viral Infections Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Mar, 2004 | Pubmed ID: 14993880 A Strategy for Treatment of Epstein-Barr Virus-positive Hodgkin's Disease by Targeting Interleukin 12 to the Tumor Environment Using Tumor Antigen-specific T Cells Cancer Gene Therapy. Feb, 2004 | Pubmed ID: 14685154 Adoptive T-cell Therapy for EBV-associated Post-transplant Lymphoproliferative Disease Acta Haematologica. 2003 | Pubmed ID: 14583674 Immunotherapy for Epstein-Barr Virus-associated Cancers in Children The Oncologist. 2003 | Pubmed ID: 12604735 Current Opinion in Molecular Therapeutics. Oct, 2002 | Pubmed ID: 12435048 Adapting a Transforming Growth Factor Beta-related Tumor Protection Strategy to Enhance Antitumor Immunity Blood. May, 2002 | Pubmed ID: 11964281 Epstein-Barr Virus-specific Human T Lymphocytes Expressing Antitumor Chimeric T-cell Receptors: Potential for Improved Immunotherapy Blood. Mar, 2002 | Pubmed ID: 11877273 Расширение цитотоксических Т-лимфоцитов из пуповинной крови, что целевая цитомегаловирус, вирус Эпштейна-Барр Вирус, и аденовирус Patrick J. Hanley1, Sharon Lam1,2, Elizabeth J. Shpall3, Catherine M. Bollard1,2,4,5 1Center for Cell and Gene Therapy, Baylor College of Medicine, 2Pathology and Immunology, Baylor College of Medicine, 3Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, 4Medicine, Baylor College of Medicine, 5Department of Pediatrics, Baylor College of Medicine JoVE 3627 면역학 및 감염병학
Расширение цитотоксических Т-лимфоцитов из пуповинной крови, что целевая цитомегаловирус, вирус Эпштейна-Барр Вирус, и аденовирус Patrick J. Hanley1, Sharon Lam1,2, Elizabeth J. Shpall3, Catherine M. Bollard1,2,4,5 1Center for Cell and Gene Therapy, Baylor College of Medicine, 2Pathology and Immunology, Baylor College of Medicine, 3Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, 4Medicine, Baylor College of Medicine, 5Department of Pediatrics, Baylor College of Medicine JoVE 3627 면역학 및 감염병학